Cleared Traditional

K880925 - DISPOSABLE WET FIELD ERASER

K880925 is an FDA 510(k) clearance for DISPOSABLE WET FIELD ERASER, manufactured by Advanced Surgical Products, Inc.. The device is a Class 2 Neurology device with product code GXI cleared through the Traditional 510(k) pathway after a 40-day FDA review.

K880925 · Advanced Surgical Products, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1988
Decision
40d
Days
Class 2
Risk

K880925 is an FDA 510(k) clearance for the DISPOSABLE WET FIELD ERASER. Classified as Probe, Radiofrequency Lesion (product code GXI), Class II - Special Controls.

Submitted by Advanced Surgical Products, Inc. (Chesterfield, US). The FDA issued a Cleared decision on April 13, 1988 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4725 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Advanced Surgical Products, Inc. devices

FDA 510(k) Submission Details - K880925

510(k) Number K880925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1988
Decision Date April 13, 1988
Days to Decision 40 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 148d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXI Device Classification - Class 2, Special Controls

Product Code GXI Probe, Radiofrequency Lesion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXI Probe, Radiofrequency Lesion

All 59
Devices cleared under the same product code (GXI) and FDA review panel - the closest regulatory comparables to K880925.
RADIONICS DISPOSABLE RF CANNULAE (SC-C, RFK-DB, RFK-DS)
K980430 · Radionics, Inc. · Mar 1998
MODIFIED DISPOSABLE COAXIAL BIPOLAR PEN
K884347 · Advanced Surgical Products, Inc. · Dec 1988
STORZ DISPOSABLE BIPOLAR PENCILS
K882802 · Storz Instrument Co. · Aug 1988
DISPOSABLE COAXIAL BIPOLAR PEN P/N 00150
K880951 · Advanced Surgical Products, Inc. · Apr 1988
THE STORZ BIPOLAR PENCIL AND CORD
K880293 · Storz Instrument Co. · Mar 1988
SMK SLUYTER-MEHTA CANNULAE, RF POLE, POLE,FLEXIBLE
K870028 · Radionics, Inc. · Oct 1987